Veterinary Pathology is the premier international publication of basic and applied research involving domestic, laboratory, wildlife, marine and zoo animals, and poultry. Bridging the divide between natural and experimental diseases, the journal details the diagnostic investigations of natural and emerging diseases of animals; reports experimental studies enhancing understanding of the mechanisms of specific processes including cancer, infection, immunologic, metabolic and genetically mediated diseases; provides unique insights into animal models of human disease; and presents studies in identification and characterization of environmental (food, plant and chemical) and pharmaceutical hazards.
Written for veterinary pathologists, veterinary diagnostic laboratory staff, toxicologic pathologists, comparative pathologists, medical pathology researchers, environmental scientists, and others involved in veterinary diagnosis and animal research across all animal species, each issue features original articles, in-depth reviews, brief communications and unique case reports. Veterinary Pathology is at the forefront of important issues including emerging disease trends, biothreat, genetic modification of animals, food, chemical and drug safety, environmental monitoring, and diagnostic technologies.
The members of the distinguished editorial board are all internationally recognized in their specialty areas and have achieved awards and recognition attendant with their thought leader reputation.
Among the important topics covered are:
- Cancer Diagnosis and Prognosis
- Diseases Linked With the Environment
- Etiology and Pathogenesis
- Genetically modified animals
- Genomic, Proteomic and Imaging Technology
- Infectious Diseases
- Xenobiotic Injury
Special Focus Issues
Special Focus: SARS-CoV-2 and Other Zoonotic Respiratory Coronaviruses in Animals (July 2022)
Special Focus: Diagnostic Veterinary Oncologic Pathology (September 2021)
The September 2021 issue provides a series of original and review articles that seek further answers to some of the enduring questions of veterinary oncologic pathology. For the diagnostic veterinary pathologist, oncologic pathology remains the cornerstone of any surgical pathology service. With advancements in immunohistochemistry, in situ hybridization, and molecular analysis, we are better able to refine our diagnoses and provide valuable data that can be used in prognostic studies. Over the last decade, interest in using spontaneously arising neoplasia in companion animals as models for similar human cancers has been renewed and revitalized. These include common but devastating neoplasms such as osteosarcoma, melanoma, and glioma. While there remains much to be elucidated about the pathogenesis and prognosis of companion animal cancer, the articles presented herein provide a window into some of the advancements and refinements that have occurred over the last decade and offer new avenues of exploration.
Special Focus: Regulated Cell Death: Emerging Mechanisms and Current Perspectives in Biology and Pathology (July 2021)
Special Focus: Veterinary Forensic Pathology (September 2016)
Special Focus: Investigative Techniques (January 2014)
The January 2014 issue presents a series of articles on investigative techniques used by pathologists in different settings. For many years, hematoxylin and eosin (HE) and other histochemical stains were the main and typically the sole methodology to evaluate disease processes. Electron microscopy (EM), although used sporadically, contributed to the identification of pathogens and the study of disease processes. In the early 1970s, immunohistochemistry (IHC) started to play a role in the identification of pathogens, cell components, and neoplasia. The next significant leap in our ability to understand diseases came with the use of genomics to decipher changes in nucleic acids. These technological advances resulted in the identification of new diseases, reclassification of pathogens, and increased understanding of neoplasia and other entities in human beings and, to a lesser extent, in animals. Next-generation sequencing has a tremendous potential to elucidate the disease process and is currently used in many human and some animal diseases.
Special Focus: Diseases of Aquatic Animals (May 2013)
The May 2013 issue presents a series of articles on diseases of aquatic animals. These animals represent an integral component of the species diversity on this planet. Articles in this special focus issue reflect this amazing diversity and criticality of aquatic animals in maintaining the integrity of the aquatic ecosystem. Aquatic animals play an essential role as monitors of the health and wholesomeness of our aquatic environment. They are an important food source. They enrich our human existence with their beauty, grace, and sometimes downright weirdness. Aquarium exhibits of an unseen world are an ever-popular entertainment and education source. Given the importance of aquatic animals in our lives and in the world as a whole, threats to aquatic existence, including disease and environmental issues, must be identified and methods developed to ensure the continuation and sustainability of these amazing life forms well into the future.
Special Focus: Toward a Better Understanding of Mouse Models of Disease (January 2012)
The January 2012 issue focuses on te use of genetically engineered mice in biomedical research forms a cornerstone for advancing our understanding of disease. The phenotyping of mutant mice creates a foundation for defining the normal biology associated with the manipulated gene. However, extensive variation in background lesions and responses to myriad endemic infectious agents, even between in-bred laboratory mouse strains, complexes interpretations of histopathologic findings. The challenges in the evaluation of the genetic manipulation of mice, as an independent variable, should not be underestimated. This special focus issue highlights some of these confounding factors, as well as includes GEM phenotyping information not previously gathered together and/or presented in journal format. This issue will emphasize some of the complexities in evaluating gene modifications in mice and will serve as a reference and a resource for pathologists and researchers alike, in their search to better understand genetic function and disease.
Special Focus: Diagnosis and Prognosis of Companion Animal Neoplastic Diseases (January 2011)
The January 2011 issue focuses on veterinary oncology. A lead manuscript, “Recommended Guidelines for the Conduct and Evaluation of Prognostic Studies in Veterinary Oncology,” represents the consensus of an international group of veterinary pathologists, oncologists, and epidemiologists, highlighting the importance of close collaboration among veterinary pathologists and oncologists to advance our abilities to diagnose, prognosticate, and successfully treat animal cancer. A series of manuscripts focus on the current state of prognostication and diagnosis of canine neoplastic diseases, including melanomas, mast cell tumors, mammary carcinomas, soft tissue sarcomas, myeloid leukemias, and lymphomas. Additional consensus manuscripts address the trimming, margin evaluation, and reporting of surgical biopsy samples, the classification of canine malignant lymphomas, and the grading of mast cell tumors. Additional review papers provide detailed insight into current techniques for the diagnosis of neoplastic disease, such as flow cytometry, and highlight the importance of integrating recently gained molecular understanding, such as loss of heterozygocity, into the evaluation of neoplastic diseases. With the emerging use of dogs and cats as models for human neoplastic diseases, well established and uniformly applied criteria to classify companion animal neoplastic disease will form a cornerstone in extrapolation of learnings across species.
Special Focus: Research Challenges and Animal Models in Biological Defense (September 2010)
The September 2010 issue focuses on research challenges and animal models in biological defense. Medical countermeasures against deadly biological select agents like anthrax, Ebola virus, smallpox and highly pathogenic influenza viruses are greatly needed to combat infections that may arise naturally or through acts of bioterrorism or biowarfare. Animal diseases involving such agents are important in their own right or as models of human infections necessary to develop vaccines, therapeutics or other countermeasures. The articles in this issue illustrate the many scientific, regulatory, safety and security challenges that research with biological select agents and toxins must overcome. They also provide a current knowledge base for animal models of several major select agents. A profound expansion of biomedical defense efforts in the United States and other countries in the last decade has provided numerous opportunities at established and recently minted facilities around the world. This issue seeks to engender, among pathologists and biologists of many disciplines, a better understanding of existing biological threats in order to show the way forward and promote the development of the medical countermeasures.
Special Focus: Emerging Diseases and Global Surveillance (January 2010)
The January 2010 issue focuses on emerging and expanding diseases that have caused significant disruptions in recent years. Bird ‘flu, foot-and-mouth disease, bluetongue, and melamine - all emerged in new places or new hosts to cause economic or public health panics. The articles chronicle the underlying reasons and highlight the global disparities in recognition and response capacities, which will ensure continuing emergence. Opportunities abound for recognizing emerging diseases, creating sound public policies, and promoting programs that protect agricultural and public health. This issue encourages animal health communities, in cooperation with local, state, federal, and international agencies, to develop proactive cooperative programs designed to detect and limit these outbreaks.
This journal is a member of the Committee on Publication Ethics (COPE).
Veterinary Pathology, an international peer-reviewed journal of natural and experimental disease, publishes manuscripts, reviews, brief communicatons, case reports, editorials, letters, and advertisements for employment opportunities and new products.
|Joshua Webster||Genentech, USA|
|Patricia Pesavento||University of California - Davis, USA|
|Jens P. Teifke||Friedrich-Loeffler-Institut, Germany|
|Mitsuru Kuwamura||Osaka Metropolitan University, Japan|
|Jennifer Johns||Oregon State University, USA|
|Jerrold M. Ward||Global Vet Pathology, USA|
|Hibret Adissu||AstraZeneca, USA|
|Eric Blomme||AbbVie Laboratories, USA|
|Christiane Löhr||Oregon State University, USA|
|Fernanda Castillo-Alcala||Massey University, New Zealand|
|Linden Craig||University of Tennessee, USA|
|Taryn Donovan||Animal Medical Center, USA|
|Ingeborg Langohr||Sanofi, USA|
|Deborah M. Gillette|
|Hannah Bender||Genentech, USA|
|Silvia Ferro||University of Padova, Italy|
|Linda Herosian||Em&En Designs|
|Piper Treuting||Seagen, USA|
|Lesly Acosta||Polytechnic University of Catalonia, Spain|
|Verena Affolter||University of California-Davis, USA|
|Giancarlo Avallone||University of Bologna, Italy|
|Jeremy Bearss||US Army Veterinary Corps, USA|
|Amanda Beck||Albert Einstein College of Medicine, USA|
|Christof Bertram||University of Veterinary Medicine Vienna, Austria|
|Mark Chalkley||IDEXX Laboratories, USA|
|James Chambers||University of Tokyo, Japan|
|Timothy Cooper||Laulima Government Solutions/NIAID, USA|
|A. Sally Davis||Kansas State University, USA|
|Olga Gonzalez||Southwest National Primate Research Center, USA|
|Sushan Han||Colorado State University, USA|
|Takeshi Izawa||Osaka Prefecture University, Japan|
|Laura Janke||St. Jude Children’s Research Hospital, USA|
|Yava Jones-Hall||Texas A&M University, USA|
|Anja Kipar||University of Zurich, Switzerland|
|Rebecca Kohnken||AbbVie, USA|
|Thijs Kuiken||Erasmus University Medical Centre, Netherlands|
|Elise LaDouceur||Joint Pathology Center, USA|
|Klaus Langohr||Polytechnic University of Catalonia, Spain|
|Elizabeth Mauldin||University of Pennsylvania, USA|
|Sebastien Monette||Memorial Sloan Kettering Cancer Center, USA|
|Tomoaki Murakami||Tokyo University of Agriculture and Technology, Japan|
|Alisa Newton||Disney’s Animals, Science and Environment, USA|
|Ilaria Porcellato||University of Perugia, Italy|
|Brian Porter||Texas A&M University, USA|
|Simon Priestnall||The Royal Veterinary College, UK|
|Enrico Radaelli||University of Pennsylvania, USA|
|Roberta Rasotto||Histopathology Consultant, Italy|
|Lorenzo Ressel||University of Liverpool, UK|
|Jana Ritter||Centers for Disease Control, USA|
|Aline Rodrigues Hoffmann||University of Florida, USA|
|Sara Santagostino||Genentech, USA|
|Yuji Sunden||Tottori University, Japan|
|Leonardo Susta||University of Guelph, Canada|
|Somporn Techangamsuwan||Chulalongkorn University, Thailand|
|Reiner Ulrich||Leipzig University, Germany|
|Vanessa Vrolyk||Charles River Laboratories, Canada|
|Geoff Wood||University of Guelph, Canada|
IMPORTANT CHANGES IN MANUSCRIPT SUBMISSION, REVIEW, AND PUBLICATION!
For complete manuscript submission guidelines, please click HERE for a downloadable PDF.
SUBMISSION OF MANUSCRIPTS
SAGEtrack is the online manuscript tracking system provided by SAGE Publications. Using this system, all aspects of the review process are carried out online. To submit an article online, please go to the journal’s SAGEtrack website at http://mc.manuscriptcentral.com/vetpath.